142 related articles for article (PubMed ID: 22472963)
1. Validation of the Cannabis Abuse Screening Test in a sample of cannabis inpatients.
Legleye S; Kraus L; Piontek D; Phan O; Jouanne C
Eur Addict Res; 2012; 18(4):193-200. PubMed ID: 22472963
[TBL] [Abstract][Full Text] [Related]
2. Psychometric properties of the CAST and SDS scales in young adult cannabis users.
Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A
Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300
[TBL] [Abstract][Full Text] [Related]
3. Optimal scaling of the CAST and of SDS Scale in a national sample of adolescents.
Bastiani L; Siciliano V; Curzio O; Luppi C; Gori M; Grassi M; Molinaro S
Addict Behav; 2013 Apr; 38(4):2060-7. PubMed ID: 23396173
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents.
Legleye S; Piontek D; Kraus L
Drug Alcohol Depend; 2011 Jan; 113(2-3):229-35. PubMed ID: 20869178
[TBL] [Abstract][Full Text] [Related]
5. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults.
Bashford J; Flett R; Copeland J
Addiction; 2010 Apr; 105(4):615-25. PubMed ID: 20403014
[TBL] [Abstract][Full Text] [Related]
6. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.
Martin G; Copeland J; Gates P; Gilmour S
Drug Alcohol Depend; 2006 Jun; 83(1):90-3. PubMed ID: 16310973
[TBL] [Abstract][Full Text] [Related]
7. Properties of the Cannabis Abuse Screening Test (CAST) in the general population.
Legleye S; Guignard R; Richard JB; Ludwig K; Pabst A; Beck F
Int J Methods Psychiatr Res; 2015 Jun; 24(2):170-83. PubMed ID: 26077195
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Cannabis Abuse Screening Test in Hungarian samples of adolescents and young adults.
Gyepesi A; Urbán R; Farkas J; Kraus L; Piontek D; Paksi B; Horváth G; Magi A; Eisinger A; Pilling J; Kökönyei G; Kun B; Demetrovics Z
Eur Addict Res; 2014; 20(3):119-28. PubMed ID: 24217457
[TBL] [Abstract][Full Text] [Related]
9. The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties.
Martin G; Copeland J; Gilmour S; Gates P; Swift W
Addict Behav; 2006 Dec; 31(12):2238-48. PubMed ID: 16626880
[TBL] [Abstract][Full Text] [Related]
10. How to screen for problematic cannabis use in population surveys: an evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults.
Annaheim B; Rehm J; Gmel G
Eur Addict Res; 2008; 14(4):190-7. PubMed ID: 18583916
[TBL] [Abstract][Full Text] [Related]
11. The DSM Guided Cannabis Screen (DSM-G-CS): description, reliability, factor structure and empirical scoring with a clinical sample.
Alexander D; Leung P
Addict Behav; 2011 Nov; 36(11):1095-100. PubMed ID: 21741769
[TBL] [Abstract][Full Text] [Related]
12. A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents.
Legleye S; Piontek D; Kraus L; Morand E; Falissard B
Int J Methods Psychiatr Res; 2013 Mar; 22(1):16-26. PubMed ID: 23519957
[TBL] [Abstract][Full Text] [Related]
13. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria.
Degenhardt L; Coffey C; Carlin JB; Swift W; Patton GC
Drug Alcohol Depend; 2008 Jan; 92(1-3):86-90. PubMed ID: 17716830
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study.
Cantillano V; Del Villar P; Contreras L; Martínez D; Zuzulich MS; Ramírez C; Pons C; Bashford J
Drug Alcohol Depend; 2017 Jan; 170():32-36. PubMed ID: 27866060
[TBL] [Abstract][Full Text] [Related]
15. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample.
Adamson SJ; Sellman JD
Drug Alcohol Rev; 2003 Sep; 22(3):309-15. PubMed ID: 15385225
[TBL] [Abstract][Full Text] [Related]
16. The Cannabis Problems Questionnaire: factor structure, reliability, and validity.
Copeland J; Gilmour S; Gates P; Swift W
Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867
[TBL] [Abstract][Full Text] [Related]
17. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
[TBL] [Abstract][Full Text] [Related]
18. The Cannabis Abuse Screening Test and the DSM-5 in the general population: Optimal thresholds and underlying common structure using multiple factor analysis.
Legleye S
Int J Methods Psychiatr Res; 2018 Jun; 27(2):e1597. PubMed ID: 29124816
[TBL] [Abstract][Full Text] [Related]
19. Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample.
Luquiens A; Berger-Viergat A; Larrieu A; Artigaud L; Fener C; Adamson S; Laprévote V; Rolland B
Drug Alcohol Rev; 2021 Nov; 40(7):1334-1339. PubMed ID: 33855757
[TBL] [Abstract][Full Text] [Related]
20. [Spanish adaptation and validation of The Adolescent-Cannabis Problems Questionnaire (CPQ-A)].
Fernández-Artamendi S; Fernández-Hermida JR; García-Cueto E; Secades-Villa R; García-Fernández G; Barrial-Barbén S
Adicciones; 2012; 24(1):41-9. PubMed ID: 22508016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
